William Wong
Nessuna posizione attualmente
Profilo
William Wong is the founder of Treventis Corp.
which was founded in 2008.
He held principal positions at Becton, Dickinson & Co., EIDP, Inc., Lynx Therapeutics, Inc., Nexell Therapeutics, Inc., Zynaxis, Inc., and Intracel Corp.
He was also a Vice President-Product Development at Q-RNA, Inc. from 2002 to 2006 and Chief Scientific Officer at Woodbrook Group Holdings, Inc. in 2006.
Dr. Wong earned a doctorate degree from the University of Rochester.
Precedenti posizioni note di William Wong
| Società | Posizione | Fine |
|---|---|---|
| WOODBROOK GROUP HOLDINGS INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2006 |
Q-RNA, Inc.
 Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/11/2006 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Lynx Therapeutics, Inc. was a developer of genetic analysis products for the pharmaceutical, biotechnology and agriculture industries. It's MPSSTM instruments analyze millions of DNA molecules in parallel enabling genome structure characterization at an unprecedented level of resolution. MPSSTM provides comprehensive and quantitative digital information important to modern systems biology research in the pharmaceutical, biotechnology and agricultural industries. The company was headquartered in Hayward, CA. | Corporate Officer/Principal | - |
| Intracel Corp. | Corporate Officer/Principal | - |
Formazione di William Wong
| Rochester Christian University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| WOODBROOK GROUP HOLDINGS INC. | Finance |
| Aziende private | 7 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Lynx Therapeutics, Inc. was a developer of genetic analysis products for the pharmaceutical, biotechnology and agriculture industries. It's MPSSTM instruments analyze millions of DNA molecules in parallel enabling genome structure characterization at an unprecedented level of resolution. MPSSTM provides comprehensive and quantitative digital information important to modern systems biology research in the pharmaceutical, biotechnology and agricultural industries. The company was headquartered in Hayward, CA. | Health Technology |
Nexell Therapeutics, Inc.
 Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA. | Health Technology |
Zynaxis, Inc.
 Zynaxis, Inc. Miscellaneous Commercial ServicesCommercial Services Zynaxis, Inc. develops drug delivery systems. The company is based in Malvern, PA. Zynaxis was acquired by Vaxcel, Inc. on December 06, 1996. | Commercial Services |
| Intracel Corp. | Health Technology |
Q-RNA, Inc.
Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Health Technology |
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- William Wong
